Cross-Border Biopharma & Synthetic Biology Licensing
Targeted sourcing, asset evaluation, and bidirectional In/Out-Licensing of clinical biopharma pipelines and synthetic biology technologies.
We help international partners evaluate and deploy China's advanced biopharma, cell & gene therapy (CGT), synthetic biology, and specialized manufacturing capabilities, delivering an end-to-end pathway from bidirectional In/Out-Licensing to automated cGMP production equipment.
Founded by Tsinghua alumni with international experience · Connected across EAEU, Europe, Japan & Korea, and the Middle East
Biologics & Synthetic Biology · CGT Automation · Industrial Equipment
Aligned with International cGMP & Target Regulatory Pathways
Eurasia (EAEU) · Europe · Japan & Korea · Middle East
Sustained track record in overseas project & supply chain delivery
Core team experience in international biopharma & BD execution
Cumulative cross-border licensing and equipment delivery value
Shanghai BA Technology Co., Ltd. (BA Tech) is a China-based, globally oriented industrial collaboration and business development partner in biopharmaceuticals and synthetic biology.
BA Tech connects technology, products, industrial resources, and commercial opportunities between China and international markets, delivering integrated solutions spanning R&D collaboration, product sourcing, resource integration, international BD, and on-the-ground execution.
Grounded in rigorous technical evaluation and disciplined operational coordination, we help global partners bridge the gap from proof-of-concept to commercial-scale implementation for sustainable long-term value.
Core Advantages | Why BA Tech
Fluent in Chinese, English, Japanese, and Russian business workflows, we collaborate with qualified local regulatory specialists to support registration and compliance across target markets while mitigating cross-border execution risk.
Our core team combines Tsinghua academic roots with seasoned international industry leadership across biologics, automated bioprocessing, and cGMP compliance, guiding technical evaluation, partner matching, deal structuring, and execution.
We go beyond licensing introductions and one-off procurement, coordinating critical equipment integration alongside steady-state reagent and consumable supply to sustain long-term commercial value.
Building an end-to-end international execution framework, from frontier asset licensing to automated equipment delivery and resilient supply chain coordination.
Targeted sourcing, asset evaluation, and bidirectional In/Out-Licensing of clinical biopharma pipelines and synthetic biology technologies.
Collaborating with specialized domestic engineering partners to deliver cGMP-compliant, automated production systems ready for process validation.
Leveraging China's advanced bioprocess equipment network for equipment selection, commissioning, training, and ongoing service.
Cross-border collaborations spanning innovative drug licensing, automated cell therapy processes and equipment delivery, sterile medical supply chains, and synthetic biology scale-up across Eurasia, Europe, and Asia-Pacific.
Novel Gene Therapy · Multi-Center Clinical Trials
Sterile Tube Welding · Matched Consumables · Steady Supply
Tube Welders · All-in-One & Modular CAR-T Systems · Pharma & CDMOs
Biomanufacturing IP Licensing · 1,000L Pilot-to-Commercial Scale-Up · Line Engineering
Regenerative Medicine · Automated Cell Processing · Modular Platform
Novel Gene Therapy · Multi-Center Clinical Trials
Facilitated the cross-border out-licensing of a proprietary Phase III AAV gene therapy developed in China. Coordinated the licensee's Phase III bridging clinical trials in target EAEU jurisdictions, alongside clinical supply and post-approval commercial drug supply.
Sterile Tube Welding · Matched Consumables · Steady Supply
Supplied integrated high-precision sterile tube welders and matched single-use consumables to national and commercial blood centers, apheresis centers, and hospitals, supported by ongoing technical maintenance and local service to safeguard closed-system sterility.
Tube Welders · All-in-One & Modular CAR-T Systems · Pharma & CDMOs
Met strict aseptic closed-system and compliance standards for leading Japanese pharmaceutical manufacturers and CDMOs, delivering validated precision sterile tube welders, All-in-One CAR-T systems, modular processing equipment, and matched sterile consumables for commercial operations.
Biomanufacturing IP Licensing · 1,000L Pilot-to-Commercial Scale-Up · Line Engineering
Advanced cross-border IP licensing and industrial collaboration for a synthetic biology single-cell protein (SCP) biomanufacturing platform, supporting process engineering, core equipment selection, and commercial line development from 1,000L pilot validation to commercial scale.
Regenerative Medicine · Automated Cell Processing · Modular Platform
Supported a Swiss biotech company's transition from manual handling to closed, automated cell therapy manufacturing, co-developing modular process units covering cell encapsulation, dynamic culture, automated harvesting, and aseptic filling to enable progression toward commercial-scale cGMP manufacturing.
Connecting China's universities, research institutes, and biopharma and life science supply network to align with overseas partners' R&D, product sourcing, and manufacturing requirements, driving cross-border technology collaboration and commercialization.
Focusing on differentiated antibody and cell & gene therapy (CGT) pipelines alongside frontier synthetic biology and biomanufacturing technologies, connecting vetted R&D assets to advance technology sourcing, international licensing, and cross-border collaboration.
Integrating bioprocessing equipment, laboratory instrumentation, in vitro diagnostics (IVD), and critical reagents and consumables across R&D, process development, and manufacturing, providing overseas partners with cost-effective, dependable supply and technical support.
Leveraging our core team's deep academic ties, we connect China's leading universities, research institutes, and state key laboratories in biopharmaceuticals and bioengineering with global partners to drive translational research, technology transfer, joint R&D, and commercialization.
Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.